Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
4
×
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
4
×
life sciences
national
4
×
national blog main
national top stories
new york blog main
new york top stories
nonalcoholic steatohepatitis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
4
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
deals
europe blog main
europe top stories
gene therapy
gilead sciences
investing
philadelphia blog main
philadelphia top stories
startups
aegle therapeutics
What
cancer
4
×
roundup
bio
ahead
amid
bombast
caught
coronavirus
days
debate
develop
discussion
efforts
meso’s
miss
pandemic
pfizer’s
presidential
promise
response
tuesday’s
vaccine
viewers
abbvie’s
ambien
american
annual
asco
attendees
attention
biofourmis
biotech
bucks
camp’s
cash
celebrate
chance
chicago
city
clinical
Language
unset
Current search:
national
×
biotech
×
cancer
×
" indiana top stories "
×
" cancer immunotherapy "
×
" seattle top stories "
×
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More